Rare disease diagnostics and disease gene discovery have been revolutionized by whole-exome and genome sequencing but identifying the causative variant(s) from the millions in each individual remains challenging. The use of deep phenotyping of patients and reference genotype-phenotype knowledge, alongside variant data such as allele frequency, segregation, and predicted pathogenicity, has proved an effective strategy to tackle this issue. Here we review the numerous tools that have been developed to automate this approach and demonstrate the power of such an approach on several thousand diagnosed cases from the 100,000 Genomes Project. Finally, we discuss the challenges that need to be overcome if we are going to improve detection rates and...
The emergence of whole genome sequencing (WGS) has revolutionized the diagnosis of rare genetic diso...
PURPOSE: Genomic sequencing has become an increasingly powerful and relevant tool to be leveraged fo...
Abstract In studies of families with rare disease, it is common to screen for de novo mutations, as ...
A molecular diagnosis from the analysis of sequencing data in rare Mendelian diseases has a huge imp...
Background: Genome-wide data are increasingly important in the clinical evaluation of human disease....
Reanalysis of inconclusive exome/genome sequencing data increases the diagnosis yield of patients wi...
Funder: European Molecular Biology Laboratory; Id: http://dx.doi.org/10.13039/100013060DECIPHER (htt...
Thanks to the affordability of DNA sequencing, hundreds of thousands of individuals with rare disord...
Background In diagnosis of rare genetic diseases we face a decision as to the degree to which the se...
Advances in high-throughput genomic technologies have facilitated the collection of DNA information ...
Advances in genotyping and sequencing technologies have revolutionized the genetics of complex disea...
Next-generation sequencing has revolutionized rare disease diagnostics, but many patients remain wit...
The high prevalence of undiagnosed diseases is a major health concern throughout the world. The low ...
Collectively, rare genetic disorders affect a substantial portion of the world’s population. In most...
Copy number variations (CNVs) are genomic structural variations (deletions, duplications, or translo...
The emergence of whole genome sequencing (WGS) has revolutionized the diagnosis of rare genetic diso...
PURPOSE: Genomic sequencing has become an increasingly powerful and relevant tool to be leveraged fo...
Abstract In studies of families with rare disease, it is common to screen for de novo mutations, as ...
A molecular diagnosis from the analysis of sequencing data in rare Mendelian diseases has a huge imp...
Background: Genome-wide data are increasingly important in the clinical evaluation of human disease....
Reanalysis of inconclusive exome/genome sequencing data increases the diagnosis yield of patients wi...
Funder: European Molecular Biology Laboratory; Id: http://dx.doi.org/10.13039/100013060DECIPHER (htt...
Thanks to the affordability of DNA sequencing, hundreds of thousands of individuals with rare disord...
Background In diagnosis of rare genetic diseases we face a decision as to the degree to which the se...
Advances in high-throughput genomic technologies have facilitated the collection of DNA information ...
Advances in genotyping and sequencing technologies have revolutionized the genetics of complex disea...
Next-generation sequencing has revolutionized rare disease diagnostics, but many patients remain wit...
The high prevalence of undiagnosed diseases is a major health concern throughout the world. The low ...
Collectively, rare genetic disorders affect a substantial portion of the world’s population. In most...
Copy number variations (CNVs) are genomic structural variations (deletions, duplications, or translo...
The emergence of whole genome sequencing (WGS) has revolutionized the diagnosis of rare genetic diso...
PURPOSE: Genomic sequencing has become an increasingly powerful and relevant tool to be leveraged fo...
Abstract In studies of families with rare disease, it is common to screen for de novo mutations, as ...